Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

Track 1 : Clinical Trials and Research

Cancer research aim to enhance patient care, discovers new therapies, and improves existing medications. These trials are rigorously supervised studies designed to assess the safety, effectiveness, and optimal use of new drugs, treatments, or diagnostic methods.

Track 1-1 Designing Clinical Trials
Track 1-2 Phases of Clinical Trials
Track 1-3 Ethical Considerations
Track 1-4 Data Analysis and Interpretation
Track 1-5 Patient Recruitment and Retention

Track 2 : Cancer Treatment

Precision medicine in cancer treatment tailors care to the specific characteristics of each patient’s cancer, such as its molecular, genetic, and phenotypic traits. This approach identifies particular mutations and biomarkers that guide the selection of targeted therapies, ensuring more effective and personalized treatment plans. Advanced diagnostics, including genome sequencing, play a key role in supporting this individualized approach.

Track 2-1 Genomic Profiling
Track 2-2 Tailored Drug Therapies
Track 2-3 Personalized Treatment Plans
Track 2-4 Pharmacogenomics
Track 2-5 Clinical Trials and Data Integration

Track 3 : Therapeutic Strategies

Cancer treatment strategies encompass various therapies designed to specifically target and destroy cancer cells. These include radiation therapy, which uses high-energy rays to eliminate tumours; chemotherapy, and targeted therapies.

Track 3-1 Chemotherapy
Track 3-2 Radiation Therapy
Track 3-3 Targeted Therapies
Track 3-4 Immunotherapy
Track 3-5 Hormonal Therapy

Track 4 : Cancer Biology

Throughout our lives, our cells are genetically programmed to perform various functions. Cells that become damaged or age naturally die and must be replaced by new ones. A tumour often referred to as a “mass,” result from the uncontrolled proliferation of cells caused by genetic mutations. In the context of cancer, this term signifies the growth of abnormal tissue.

Track 4-1 Genetic Mutations and Their Role in Cancer
Track 4-2 The Tumour Microenvironment
Track 4-3 Oncogenes and Tumour Suppressor Genes
Track 4-4 Cell Signalling Pathwa
Track 4-5 Cancer Stem Cells

Track 5 : Cancer Genetics

Cancer genetics is the study of genetic changes that drive the initiation and progression of cancer. It examines how both somatic mutations and inherited genetic variations contribute to tumour formation, growth, and spread.

Track 5-1 Inherited Cancer Syndromes
Track 5-2 Genetic Risk Assessment
Track 5-3 Gene Editing Technologies
Track 5-4 Epigenetics and Cancer
Track 5-5 Genetic Counselling

Track 6 : Cancer Immunology

This session explores the complex interactions between the immune system and cancer cells, aiming to understand how these relationships influence tumour growth and treatment responses. Key areas of study include how immune cells target cancer, the mechanisms tumours use to evade immune detection, and advancements in immunotherapies such as checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines.

Track 6-1 Tumour Antigens
Track 6-2 Immune Checkpoint Inhibitors
Track 6-3 CAR-T Cell Therapy
Track 6-4 Cancer Vaccines
Track 6-5 Tumour-Infiltrating Lymphocytes

Track 7 : Paediatric Oncology

Focused on the diagnosis and treatment of cancer in children and adolescents, paediatric oncology addresses the unique aspects of cancer in younger populations, including distinct tumour types, treatment side effects, and issues related to long-term survivorship.

Track 7-1 Common Paediatric Cancers
Track 7-2 Long-Term Effects of Treatment
Track 7-3 Innovative Therapies
Track 7-4 Supportive Care for Paediatric Patients
Track 7-5 Family and Psychological Support

Track 8 : Hematologic Cancer

Hematologic cancer originate in the blood, bone marrow, or lymphatic system and include conditions like leukaemia (affecting blood and bone marrow), lymphoma (affecting the lymphatic system), and multiple myeloma (impacting plasma cells in bone marrow).

Track 8-1 Leukaemia
Track 8-2 Lymphomas
Track 8-3 Multiple Myeloma
Track 8-4 Bone Marrow Disorders
Track 8-5 Advances in Hematologic Treatments

Track 9 : Cancer Metastasis

Cancer metastasis is the process through which cancer cells spread from the primary tumour site to other parts of the body. This complex process involves local invasion, entry into the lymphatic or blood circulation, travel to distant organs, and the establishment of secondary tumours at new sites.

Track 9-1 Mechanisms of Metastasis
Track 9-2 Metastatic Sites and Patterns
Track 9-3 Targeting Metastatic Spread
Track 9-4 Role of the Microenvironment
Track 9-5 Experimental Models and Techniques

Track 10 : Early Detection and Diagnosis

Early detection and diagnosis are critical for treating cancer in its most manageable stages. This session explores screening techniques like Pap smears, mammograms, and colonoscopies, as well as advanced imaging technologies, such as MRI and CT scans. Innovations like genetic testing and liquid biopsies are further enhancing the ability to detect cancer early with greater accuracy.

Track 10-1 Screening Technique
Track 10-2 Biomarkers in Early Detection
Track 10-3 Imaging Technologies
Track 10-4 Liquid Biopsies
Track 10-5 Genetic Testing and Personalized Diagnosis

Track 11 : Drug Development

Drug development for cancer involves identifying, testing, and bringing new cancer therapies to the market. The process begins by pinpointing potential therapeutic targets through genetic and biological research on cancer. Preclinical studies then test the new compound’s safety and effectiveness in lab models before moving into clinical trials, where the treatment's safety, efficacy, and optimal dosage are evaluated in humans.

Track 11-1 Preclinical Testing
Track 11-2 Phase I, II, III Trials
Track 11-3 Regulatory Approval
Track 11-4 Post-Marketing Surveillance
Track 11-5 Drug Repurposing

Track 12 : Cancer Prevention

This session addresses strategies aimed at reducing cancer risk through lifestyle and preventative measures. These include adopting healthier habits like balanced nutrition, regular physical activity, and avoiding known carcinogens such as tobacco and excessive alcohol consumption.

Track 12-1 Lifestyle and Environmental Factors
Track 12-2 Vaccination
Track 12-3 Nutritional Interventions
Track 12-4 Public Health Strategies
Track 12-5 Genetic Risk Reduction

Track 13 : Cancer and Aging

The relationship between aging and cancer is explored in this session, highlighting that as individual’s age, their risk of cancer increases due to cumulative genetic mutations and weakened cellular repair systems. Older adults face unique challenges in cancer treatment, including managing other health issues and potential side effects.

Track 13-1 Age-Related Cancer Risks
Track 13-2 Geriatric Oncology
Track 13-3 Treatment Considerations in Older Adults
Track 13-4 Survivorship and Aging
Track 13-5 Multidisciplinary Approaches

Track 14 : Molecular and Cellular Techniques

This session focuses on advanced methods for studying and manipulating cancer cells at the molecular level to support cancer treatment and research.

Track 14-1 CRISPR and Gene Editing
Track 14-2 Single-Cell Sequencing
Track 14-3 Proteomics and Metabolomics
Track 14-4 High-Throughput Screening
Track 14-5 Bioinformatics Tools

Track 15 : Patient-Centred Care

Emphasizing a personalized approach, this session at cancer 2025 explores tailoring care to meet each patient’s specific needs and preferences. It includes creating individualized cancer treatment plans, providing comprehensive support, and fostering patient engagement.

Track 15-1 Quality of Life Assessments
Track 15-2 Palliative and Supportive Care
Track 15-3 Patient-Physician Communication
Track 15-4 Psychosocial Support
Track 15-5 Patient Advocacy and Rights

Track 16 : Cancer Epidemiology

Cancer epidemiology examines the patterns, causes, and trends of cancer within populations, including risk factors, geographical differences, and trends in incidence and prevalence.

Track 16-1 Cancer Incidence and Prevalence
Track 16-2 Risk Factors and Correlations
Track 16-3 Geographical Variations
Track 16-4 Surveillance and Monitoring
Track 16-5 Data Collection and Analysis

Track 17 : Surgical Oncology

This session covers the surgical removal of cancerous tissues in various cancers, focusing on advanced surgical techniques and innovations. Surgical oncologists may remove tumours, nearby lymph nodes, and some surrounding healthy tissues to achieve optimal outcomes.

Track 17-1 Minimally Invasive Surgery
Track 17-2 Robotic-Assisted Surgery
Track 17-3 Oncological Resections
Track 17-4 Reconstructive Surgery
Track 17-5 Surgical Innovations and Outcomes

Track 18 : Radiology in Oncology

Also known as radiation oncology or therapeutic radiology, this field focuses on using radiation treatments to target and manage cancer, along with certain other conditions. In oncology, radiation plays a crucial role in diagnosing and treating cancer by utilizing various forms to destroy cancer cells and prevent their spread.

Track 18-1 Advanced Imaging Techniques
Track 18-2 Interventional Radiology
Track 18-3 Radiomics and Imaging Biomarkers
Track 18-4 Radiotherapy Planning
Track 18-5 Patient Safety and Quality Assurance

Track 19 : Cancer Pharmacology

This session explores the study of molecular pathways associated with cell growth and cell death, the action mechanisms of cancer drugs, the development of new therapies, the underlying processes in DNA damage and repair, and advancements in gene therapy strategies.

Track 19-1 Mechanisms of Drug Action
Track 19-2 Pharmacokinetics and Pharmacodynamics
Track 19-3 Toxicity and Side Effects
Track 19-4 Drug Interactions
Track 19-5 Novel Drug Classes

Track 20 : Cancer and Nutrition

Nutrition plays a critical role in cancer, influencing cancer risk, the body’s response to treatment, and overall well-being both during and after therapy. This session examines key nutritional factors in cancer prevention and management.

Track 20-1 Nutritional Needs During Treatment
Track 20-2 Impact of Diet on Cancer Progression
Track 20-3 Supplements and Complementary Therapies
Track 20-4 Nutritional Counselling
Track 20-5 Diet and Prevention

Track 21 : Cancer Survivorship

Cancer survivorship focuses on providing comprehensive care and support to individuals who have completed cancer treatment. It includes managing lasting side effects, addressing both physical and emotional needs, and monitoring for any recurrence. Survivorship care plans are tailored to guide on going care and promote a healthy lifestyle.

Track 21-1 Long-Term Effects of Cancer Treatment
Track 21-2 Rehabilitation and Recovery
Track 21-3 Survivorship Care Plans
Track 21-4 Mental Health and Wellness
Track 21-5 Community Resources and Support

Track 22 : Integrative Oncology

This approach aims to improve patient outcomes by combining conventional cancer therapies with complementary practices. Integrative oncology merges standard treatments with therapies like acupuncture, meditation, and nutritional guidance to address the physical, mental, and emotional needs of the patient.

Track 22-1 Complementary Therapies
Track 22-2 Mind-Body Practices
Track 22-3 Combining Conventional and Alternative Medicine
Track 22-4 Patient Preferences and Efficacy
Track 22-5 Safety and Regulation

Track 23 : Health Disparities in Cancer

It refers to the unequal burden and treatment outcomes experienced by different populations, often influenced by race, ethnicity, socioeconomic status, and geographic location. These disparities can impact cancer incidence, survival rates, and access to quality care.

Track 23-1 Access to Care
Track 23-2 Socioeconomic Factors
Track 23-3 Racial and Ethnic Disparities
Track 23-4 Geographic Variations
Track 23-5 Strategies for Equity

Track 24 : Global Oncology

Global oncology addresses the differences and challenges in cancer care, prevention, and research across regions. This field promotes global collaboration for sharing knowledge, resources, and strategies aimed at reducing cancer burden worldwide.

Track 24-1 Cancer Burden Worldwide
Track 24-2 International Collaborative Research
Track 24-3 Healthcare Infrastructure
Track 24-4 Global Health Initiatives
Track 24-5 Cultural Considerations in Treatment

Track 25 : Future Directions in Oncology

The future of oncology is shaped by advancements in technology and personalized medicine, paving the way for transformative cancer treatments. Emerging areas include the application of machine learning and artificial intelligence for predictive diagnostics, early detection, and optimizing treatment plans.

Track 25-1 Emerging Technologies
Track 25-2 Innovations in Treatment
Track 25-3 Next-Generation Sequencing
Track 25-4 Machine Learning and Artificial Intelligence
Track 25-5 Future Research Trends

Track 26 : Case Reports and Case Studies

This session highlights impactful case reports and case studies, providing valuable insights into rare cancer presentations, unique treatment responses, and challenges encountered in cancer management. Through these real-world examples, attendees will gain a deeper understanding of individual patient experiences and the practical application of innovative therapies and interventions. This session will emphasize critical observations that can inspire future research directions and clinical practice improvements.

Track 26-1 Rare and Uncommon Cancer Cases
Track 26-2 Treatment Outcomes and Challenges
Track 26-3 Complications and Adverse Effects in Cancer Therapy
Track 26-4 Personalized and Precision Medicine Cases
Track 26-5 Lessons from Multidisciplinary Cancer Care